Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon L Hale

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Cardiovascular Drugs and Therapy|May 27, 2004
Acetaminophen and experimental acute myocardial infarctionSharon L Hale, Robert A Kloner
Journal of Thrombosis and Thrombolysis|July 15, 2014
Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusionSharon L Hale, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|June 21, 2005
Acetaminophen and myocardial stunning after transient ischemia in rabbit heartsSharon L Hale, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|February 6, 2010
Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbitSharon L Hale, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|December 15, 2010
Mild hypothermia as a cardioprotective approach for acute myocardial infarction: laboratory to clinical applicationSharon L Hale, Robert A Kloner
Coronary Artery Disease|July 20, 2002
Elevated body temperature during myocardial ischemia/reperfusion exacerbates necrosis and worsens no-reflowSharon L Hale, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|January 16, 2007
Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbitSharon L Hale, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|July 16, 2008
The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbitSharon L Hale, Robert A Kloner
Cardiovascular Drugs and Therapy|August 13, 2014
Ranolazine treatment for myocardial infarction? Effects on the development of necrosis, left ventricular function and arrhythmias in experimental modelsSharon L Hale, Robert A Kloner
Regenerative Medicine|May 1, 2007
Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in ratsWangde Dai, Sharon L Hale, Robert A Kloner
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Cardiovascular Drugs and Therapy|May 27, 2004
Acetaminophen and experimental acute myocardial infarctionSharon L Hale, Robert A Kloner
Journal of Thrombosis and Thrombolysis|July 15, 2014
Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusionSharon L Hale, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|June 21, 2005
Acetaminophen and myocardial stunning after transient ischemia in rabbit heartsSharon L Hale, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|February 6, 2010
Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbitSharon L Hale, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|December 15, 2010
Mild hypothermia as a cardioprotective approach for acute myocardial infarction: laboratory to clinical applicationSharon L Hale, Robert A Kloner
Coronary Artery Disease|July 20, 2002
Elevated body temperature during myocardial ischemia/reperfusion exacerbates necrosis and worsens no-reflowSharon L Hale, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|January 16, 2007
Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbitSharon L Hale, Robert A Kloner
Journal of Cardiovascular Pharmacology and Therapeutics|July 16, 2008
The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbitSharon L Hale, Robert A Kloner
Cardiovascular Drugs and Therapy|August 13, 2014
Ranolazine treatment for myocardial infarction? Effects on the development of necrosis, left ventricular function and arrhythmias in experimental modelsSharon L Hale, Robert A Kloner
Regenerative Medicine|May 1, 2007
Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in ratsWangde Dai, Sharon L Hale, Robert A Kloner
Pageof 6